Author:
Iwai Kazuro,Soejima Kenzo,Kudoh Shoji,Umezato Yoshimasa,Kaneko Toru,Yoshimori Kouji,Tokuda Hitoshi,Yamaguchi Tetsuo,Mizoo Akira,Setoguchi Yasuhiro,Kamigaki Takashi,Fujimoto Katsunada,Goto Shigenori
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference41 articles.
1. Rosenberg SA (1984) Immunotherapy of cancer by systemic administration of lymphoid cell plus interleukin-2. J Biol Resp Modif 3:501–511
2. Rosenberg SA, Lotse MT, Muul LM, Vetto JT et al (1986) A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated cells and recombinant interleukin-2. Surgery 100:262–272
3. Grim EA, Mazumder A, Zhang H, Rosenberg SA (1982) Lymphnokine-activated killer cell phenomenon. Lysis of natural killer resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841
4. Hefeneider SH, Conlon PJ, Henney CS, Gllis S (1983) In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident killer cells. J Immunol 130:222–227
5. Rosenberg SA (1984) Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2. J. Biol Response Modif 3:501–511
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献